| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
SCYNEXIS Inc (NASDAQ: SCYX)
SCYX Technical Analysis
5
| As on 9th Jun 2023 SCYX STOCK Price closed @ 2.76 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.21 & Strong Sell for SHORT-TERM with Stoploss of 5.19 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SCYXSTOCK Price
| Open | 2.58 | Change | Price | % |
| High | 2.80 | 1 Day | 0.17 | 6.56 |
| Low | 2.58 | 1 Week | 0.26 | 10.40 |
| Close | 2.76 | 1 Month | -0.30 | -9.80 |
| Volume | 498300 | 1 Year | -4.73 | -63.15 |
| 52 Week High 7.50 | 52 Week Low 1.15 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| SCYX Daily Charts |
SCYX Intraday Charts |
Whats New @ Bazaartrend |
SCYX Free Analysis |
|
|
SCYX Important Levels Intraday
| RESISTANCE | 3.18 |
| RESISTANCE | 3.05 |
| RESISTANCE | 2.96 |
| RESISTANCE | 2.88 |
| SUPPORT | 2.64 |
| SUPPORT | 2.56 |
| SUPPORT | 2.47 |
| SUPPORT | 2.34 |
SCYX Forecast May 2024
| 4th UP Forecast | 6.85 |
| 3rd UP Forecast | 5.54 |
| 2nd UP Forecast | 4.73 |
| 1st UP Forecast | 3.92 |
| 1st DOWN Forecast | 1.6 |
| 2nd DOWN Forecast | 0.79 |
| 3rd DOWN Forecast | -0.02 |
| 4th DOWN Forecast | -1.33 |
SCYX Weekly Forecast
| 4th UP Forecast | 4.26 |
| 3rd UP Forecast | 3.78 |
| 2nd UP Forecast | 3.48 |
| 1st UP Forecast | 3.19 |
| 1st DOWN Forecast | 2.33 |
| 2nd DOWN Forecast | 2.04 |
| 3rd DOWN Forecast | 1.74 |
| 4th DOWN Forecast | 1.26 |
SCYX Forecast2024
| 4th UP Forecast | 14.15 |
| 3rd UP Forecast | 10.5 |
| 2nd UP Forecast | 8.24 |
| 1st UP Forecast | 5.98 |
| 1st DOWN Forecast | -0.46 |
| 2nd DOWN Forecast | -2.72 |
| 3rd DOWN Forecast | -4.98 |
| 4th DOWN Forecast | -8.63 |
SCYNEXIS Inc ( NASDAQ USA Symbol : SCYX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SCYX Business Profile
SCYNEXIS, Inc., a biotechnology company, delivers therapies for the treatment fungal infections in the United States. It is developing its lead product candidate, ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company develops ibrexafungerp, which has completed Phase II clinical trials for the treatment of vulvovaginal candidiasis. It has research collaborations with Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, and R-Pharm, CJSC to develop and commercialize rights for ibrexafungerp. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey. Address: 1 Evertrust Plaza, Jersey City, NJ, United States, 07302-6548
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service